Big Health provides FDA‑cleared, prescription‑grade digital cognitive‑behavioral therapy programs for insomnia, anxiety, and depression through mobile‑first applications that deliver interactive video/audio lessons, adaptive exercises, and real‑time progress tracking. The solution includes a secure clinician portal, FHIR‑compatible APIs, and analytics dashboards, enabling health systems, insurers, and large employers to prescribe, integrate, and reimburse scalable mental‑health care.
Funding
$5.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with insomnia, anxiety, and low mood often face long waitlists, limited access to qualified clinicians, and inconsistent quality of care, leading to delayed treatment and poorer health outcomes. Traditional in‑person CBT requires scheduled appointments and can be costly for health plans and employers.
Solution
Big Health delivers FDA‑cleared, evidence‑based digital cognitive‑behavioral therapy (CBT) programs that provide first‑line treatment for insomnia (SleepioRx), generalized anxiety disorder (DaylightRx), and depression/mood (Spark Direct). The mobile‑first applications guide users through interactive video and audio lessons, adaptive exercises, and real‑time progress tracking, all available 24/7 without waitlists. Clinicians can prescribe the programs via a secure access‑code workflow, and the treatments are reimbursable under new digital mental health treatment billing codes. Integrated analytics deliver outcome dashboards and API connectivity (FHIR‑compatible) for health‑system and payer workflows, enabling scalable, cost‑effective mental‑health care across health systems, insurers, and employers.
Target Audience
Primary customers are health‑system providers, health plans, and large employers seeking scalable, reimbursable mental‑health solutions for their patients, members, and employees (including families).
Features
- FDA‑cleared prescription digital therapeutics (SleepioRx, DaylightRx) with clinically validated CBT protocols
- Mobile app with video/audio lessons, interactive exercises, and personalized adaptive pathways
- 24/7 instant access; no appointment scheduling or waitlists required
- Secure, HIPAA and HITRUST‑compliant data handling with end‑to‑end encryption
- Clinician portal and analytics dashboard showing adherence, symptom scores, and longitudinal trends
- FHIR‑compatible API for seamless integration with EHRs, payer systems, and benefits platforms
- Prescription workflow using unique access codes and automated patient onboarding via SMS
- Backed by >100 peer‑reviewed publications, 20+ randomized controlled trials, and guideline endorsements